Etalocib
| CAS No. | 161172-51-6 | Cat. No. | BCP29555 |
| Name | Etalocib | ||
| Synonyms | VML295; VML-295; VML 295; LY293111; LY-293111; LY 293111; PDSP1001237; PDSP2001221; | ||
| Formula | C33H33FO6 | M. Wt | 544.61 |
| Description | Etalocib, also known as LY293111 and VML295, is a novel diaryl ether carboxylic acid derivative, is a potent and selective inhibitor of the lipoxygenase pathway either directly through 5'-lipoxygenase or via antagonism of the leukotriene B4 (LTB4) receptor. LY293111 has antineoplastic activity in a variety of preclinical models. | ||
| Pathways | Protease/Metabolic Enzyme GPCR/G Protein | ||
| Targets | Leukotriene Receptor Lipoxygenase | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.